Pyridostigmine for the Treatment of Constipation in Parkinson Disease
Phase 2
18+
1 site in VT
About this study
This Phase 2 study is testing Pyridostigmine Bromide in people with constipation.
Based on ClinicalTrials.gov records.
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Antimyasthenic Agents (Cholinesterase Inhibitors)
injection
Secondary: Changes from Baseline to the End of Study Visit in Beck Depression Inventory-II (BDI-II), Changes from Baseline to the End of Study Visit in the Gastrointestinal Dysfunction Scale in Parkinson's Disease (GIDS-PD), Changes from Baseline to the End of Study Visit in the MDS-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Parts I-IV, Number of adverse events and serious adverse events that occur during the trial
Neurology, Gastroenterology